News | January 27, 2023
Sun Pharma launches SEZABY in the US for treatment of neonatal seizures
SEZABY is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection
SEZABY is a benzyl alcohol-free and propylene glycol-free formulation of phenobarbital sodium powder for injection
APAC to see a reduction in imported surgical robotics
The cardiomyopathies market in the 68M is set to grow at a CAGR of 12.1%
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
The use of procalcitonin testing for sepsis management is highest in the US
_256_384.png)
Leuprolide Acetate Injection Depot contains 22.5 mg of leuprolide acetate for 3- month administration given as a single dose injection.
Latest innovations feature vendor-neutral solutions to help reduce clinical complexity and enhance operational efficiency
Investment in R&D was Rs. 337.6 crore (8.3% of sales) for Q2 FY2023 as compared to Rs. 330 crore (8.2% of sales) for Q2 FY2022.
According to IQVIA sales data for the 12-month period ending September 2022, the Gilenya Capsules, 0.5 mg market achieved annual sales of approximately US $1.8 billion
Sause will become CEO Roche Diagnostics and a member of the Corporate Executive Committee effective 1 January 2023.
Subscribe To Our Newsletter & Stay Updated
